Renal transplant outcome in high-cardiovascular risk recipients

Clinical Transplantation

Volumn 21, Issue 5, 2007, Pages 609-614

  Jeloka, Tarun K ^a   Ross, Heather ^a   Smith, Robert ^a   Huang, Michael ^a   Fenton, Stanley ^a   Cattran, Daniel ^a   Schiff, Jeffrey ^a   Cardella, Carl ^a   Cole, Edward ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Coronary artery disease risk factors; Post transplant cardiac event; Posttransplant outcome; Renal transplant

Indexed keywords

ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; GRAFT SURVIVAL; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECIPIENT; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34548611956     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00695.x     Document Type: Article

References (14)

1. Canadian Organ Replacement Register (CORR). Treatment of end-stage organ failure in Canada. Canadian Institute of Health Information 2003 and 2003: 5.
2. Renal Data System, USRDS 2005. Annual data report http://www.usrds.org.
3. Foley R, Parfrey P, Sarnak M. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 1998: 32 (Suppl. 3): S112.
4. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996: 7: 158.
5. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999: 341: 1725.
6. Kasiske BL, Chakkera HA, Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 2000: 11: 1735.
7. Ducloux D, Kazory A, Chalopin JM. Predicting coronary heart disease in renal transplant recipients: A prospective study. Kidney Int 2004: 66: 441.
8. Fellstrom B, Jardine AG, Soveri I et al. Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation. Experience from the assessment of Lescol in renal transplantation trial. Transplantation 2005: 79: 1160.
9. Meier-Kriesche HU, Schold JD, Srinivas TR, Reed A, Kaplan B. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant 2004: 4: 1662.
10. Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularization in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992: 340: 998.
11. Kasiske BL, Cangro CB, Hariharan S et al. The evaluation of renal transplant candidates: Clinical practice guidelines. Am J Transplant 2001: 2 (Suppl. 1): 5.
12. Jardine AG, Fellstrom B, Logan JO et al. Cardiovascular risk and renal transplantation: Post hoc analyses of the assessment of Lescol in renal transplantation (ALERT) study. Am J Kidney Dis 2005: 46: 529.
13. Woo YM, McLean D, Kavanagh D et al. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation. J Nephrol 2002: 15: 380.
14. McGregor E, Jardine AG, Murray LS et al. Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation. Nephrol Dial Transplant 1998: 13: 1499.